Navigation Links
Promised Drug Doesn't Help Acute Heart Failure

Intravenous administration of the drug tezosentan did not improve worsening heart failure or prevent death in patients with acute heart failure // despite high hopes. The above fact was found out in the largest international trial on acute heart failure to date. The study was conducted to evaluate if something more could be done for acute heart failure patients in order to speed up hospital discharge and prevent them from coming back.

More than 1,400 acute heart failure patients received either IV administration of the endothelin receptor antagonist called tezosentan or a placebo, plus conventional therapy. Endothelin-1 is a potent vasoconstrictor produced in the blood vessels and other tissues. Its presence is a strong predictor of mortality in acute heart failure.

No difference in dyspnea, or a significant breathing problem, for the two groups of hospitalized patients over 24 hours. After a week, there was also no difference between the placebo group and group receiving tezosentan in incidence of death or worsening of heart failure. After six months, no difference was observed in overall mortality.
'"/>




Page: 1

Related medicine news :

1. Deep Sleep Doesnt Increase Memory
2. Dental Amalgam Doesnt Pose Health Risks In Children
3. Why Immune System Doesnt Attack Small Intestine?
4. Acute Measles Supresses HIV Replication
5. Severe Acute respiratory Syndrome (SARS)
6. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
7. Acute Pancreatitis On The Rise Due To Alcohol Consumption
8. Gene Fusion Test to screen children’s with Acute Lymphoblastic Leukemi
9. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
10. Acute Gastroenteritis Responds To Treatment With Either Gatorade Or Pedialyte
11. Acute Shortage Of Neurosurgeons In India: One Surgeon For Every 1 Million!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... Petersburg, FL (PRWEB) , ... April 29, 2016 , ... Sublime Beauty® is offering a ... the same product) for 50% off. The discount is applied to the product with lesser ... is given to those who purchase $250 or more in products. , "So many women ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ProText Layouts is ... Final Cut Pro X . With ProText Layouts, video editors can create an ... match the length and scale of texts. Creating text-based videos have never been ...
(Date:4/28/2016)... ... , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has qualified to ... at the University of Montana on April 28-May 1. Varize will compete on Saturday ... order to qualify, Varize needed to place top seven all-around in her respective age ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ARRS ... attracting medical professionals from around the globe who attended a week’s worth of ... Sunday, April 17 included the introduction of the 2016 ARRS Distinguished Educator, Dr. ...
(Date:4/28/2016)... ... 28, 2016 , ... Greener Hydroponics is now offering a large selection of ... professional organic farmers and nurseries according to Sales Manager Joe Steele who says, “Now ... goal is to offer wholesale level pricing and ultra-fast shipping for growers of any ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- The blood testing market in China ... and The Freedonia Group in a recent report.  The ... healthcare research firm said that China ... and in improving testing at the provincial level.   The ... Blood Testing Market in China , which utilized ...
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
Breaking Medicine Technology: